Publications by authors named "Michael P Cohen"

Claim this Profile
S
Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1-((1,3)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor.
Junliang Hao, James P Beck, John M Schaus, Joseph H Krushinski, Qi Chen, Michael P Cohen

J Med Chem· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis.
Kjell A Svensson, Beverly A Heinz, John M Schaus, James P Beck, Junliang Hao, Michael P Cohen

J Pharmacol Exp Ther· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of selective N-[3-(1-methyl-piperidine-4-carbonyl)-phenyl]-benzamide-based 5-HT₁ F receptor agonists: Evolution from bicyclic to monocyclic cores.
Deyi Zhang, Maria-Jesus Blanco, Bai-Ping Ying, Daniel Kohlman, Sidney X Liang, Michael P Cohen

Bioorg Med Chem Lett· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats.
Jorn Arnt, Benny Bang-Andersen, Ben Grayson, Franklin P Bymaster, Michael P Cohen

Int J Neuropsychopharmacol· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis